January 2, 2026 · Form 4 insider transaction
O'Dowd Sarah A bought 2,695 shares of Protagonist Therapeutics, Inc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Represents grant of restricted stock units payable solely in common stock that will vest in full on January 15, 2027, subject to the Reporting Person's continued service to the Issuer through the vesting date.